Scott W. Morrison - 06 Oct 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
06 Oct 2022
Net transactions value
$0
Form type
4
Filing time
11 Oct 2022, 16:23:55 UTC
Previous filing
06 Oct 2022
Next filing
12 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARS Employee Stock Option (right to buy) Award $0 +14,000 $0.000000 14,000 06 Oct 2022 Common Stock 14,000 $17.21 Direct F1
transaction TARS Restricted Stock Units Award $0 +4,000 $0.000000 4,000 06 Oct 2022 Common Stock 4,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest in three equal annual installments beginning on October 6, 2023, subject to the Reporting Person's continuous service.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F3 The RSUs will vest in three equal annual installments on September 15th of each of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.